First economic evaluation of "Smoke-Free Month": a program deemed effective and generating healthcare savings

Press Contacts

Santé publique France
presse@santepubliquefrance.fr

Stéphanie Champion: 01 41 79 67 48
Marie Delibéros: 01 41 79 69 61
Camille Le Hyaric: 01 41 79 68 64

With support from Santé publique France, the OECD (Organization for Economic Cooperation and Development) is releasing a report today on the return on investment of the tobacco control policy implemented in France between 2016 and 2020.

The results show an estimated average return of 4 euros for every euro invested in effective prevention measures. These findings support efforts to combat tobacco use in France and internationally. Following an unprecedented decline in smoking prevalence in France between 2014 and 2019, the latest data published in May 2023 show a stabilization in 2022. These results therefore call for renewed action in tobacco control policies.

Particularly cost-effective tobacco control measures

The report includes an assessment of the main measures of the National Tobacco Control Program: the gradual increase in tobacco prices, the implementation of plain or standardized cigarette packaging, the reimbursement of nicotine replacement therapies, and the annual “Month Without Tobacco” initiative led by the Agency.

Simulations conducted by the OECD show that if these measures were maintained over the 2023–2050 period, they would prevent approximately 4 million cases of chronic disease, save 578 million euros per year in healthcare costs, and boost employment and labor productivity by the equivalent of 19,800 additional full-time equivalents (FTEs) per year, compared to a scenario in which they were not implemented.

Thus, their cost—estimated at approximately €148 million per year—would be offset by long-term savings in healthcare spending, with an average return of €4 for every euro invested.

These results are based on a microsimulation model developed by the OECD for strategic public health planning for noncommunicable diseases (SPHeP-NCD). Its application to the evaluation of tobacco control policies was funded by a voluntary contribution from Santé publique France, which also provided the OECD with smoking prevalence data from the Santé publique France Public Health Barometer, as well as data related to the evaluation of “Mois sans tabac” (Smoke-Free Month).

Smoke-Free Month: A Social Marketing Initiative with a High Return on Investment

The OECD also conducted an economic evaluation of Tobacco-Free Month, a social marketing initiative encouraging people to quit smoking, organized annually in November since 2016 by Santé publique France.

This initiative aims to mobilize people who want to quit smoking and support them in their efforts for one month. Since its first edition in 2016, nearly 1.2 million registrations have been recorded.

According to OECD modeling, “Mois sans tabac” is projected to reduce healthcare costs by an average of 94 million euros per year between 2023 and 2050 (at an annual cost of approximately 12 million euros). Thus, for every euro invested in “Mois sans tabac,” more than 7 euros are saved on healthcare costs due to smoking cessation.

By 2050, Tobacco-Free Month is projected to prevent, among other things: 241,000 cases of lower respiratory tract infections, 44,000 cases of chronic obstructive pulmonary disease (COPD), and 28,000 cases of cancer.

Furthermore, it would boost employment and labor productivity, with an estimated value of 85 million euros per year.

Continuing Prevention Efforts to Reduce Smoking Rates in France

Santé publique France is investing in health economics and in calculating return on investment to support its prevention efforts. In addition to the standard evaluations of its social marketing initiatives, the Agency is thus equipping itself with tools to measure the medium- and long-term impact of various interventions in terms of health gains and economic benefits. The longer-term goal is to develop this expertise within the Agency, but also through collaborations such as the one on tobacco with the OECD.

Dr. Caroline Semaille, Director General of Santé publique France

Tobacco control is one of the key pillars of Santé Publique France’s prevention policy. Its work operates on three levels: monitoring tobacco-related diseases; tracking and analyzing smokers’ behaviors and producing key indicators for tobacco control strategies; and finally, implementing and evaluating prevention initiatives, such as the “Month Without Tobacco” social marketing campaign or major national campaigns throughout the year. In addition, the “Tabac info service” smoking cessation support program recorded nearly 56,000 calls in 2022 via the 39 89 helpline, including 48,600 calls for tobacco-related assessments and follow-ups. Since May 31, 2023, the 39 89 hotline has been accessible to deaf or hard-of-hearing individuals via the Acceo platform.

Furthermore, the fight against tobacco, the leading cause of preventable death in France, is a public health issue that transcends borders. The Agency has partnered with the WHO to create a bilingual French-English knowledge platform focused on Article 12 of the Framework Convention on Tobacco Control (FCTC). Its goal is to facilitate knowledge sharing among FCTC signatory countries and to strengthen the implementation of effective tobacco control measures in these nations.

Tobacco Information Service

The tabac-info-service website is open to everyone and offers personalized, effective support to help anyone quit smoking

Tobacco

thematic dossier

Despite a slight decrease compared to 2015, tobacco remains responsible for more than 68,000 premature deaths in 2023—accounting for 11% of total mortality—making it still the leading cause of...

Our latest news

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men

news

Hervé Maisonneuve has been appointed scientific integrity officer for a...

Visuel illustratif

news

Public Health France 2026 Barometer: Launch of the Survey